Amylyx Pharmaceuticals, Inc.·4

Sep 5, 7:26 PM ET

MILNE GEORGE M JR 4

4 · Amylyx Pharmaceuticals, Inc. · Filed Sep 5, 2024

Insider Transaction Report

Form 4
Period: 2024-09-03
Transactions
  • Purchase

    Common Stock

    2024-09-03$2.20/sh+100,000$219,800858,571 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.14 to $2.235. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4